Investment
Features
FeesSafety
Academy
More
Pluang+

Compare H.M. Sampoerna Tbk. (HMSP) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

H.M. Sampoerna Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

H.M. Sampoerna Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? H.M. Sampoerna Tbk. trades at Rp695 (market cap 79.68T, 7.53M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: H.M. Sampoerna Tbk. is far larger — about 476.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and H.M. Sampoerna Tbk. is more actively traded (7.53M versus 71K). Which is the better fit depends on your goals.

HMSPOBAT
Market Cap
79.68T167.37B
Volume
7.53M71K
Lot
75.28K710
Turnover
5.2B17.51M
Average Price
690.76246.63
Value
5.2B17.51M
Indicative Equilibrium Price
695246
Indicative Equilibrium Volume
4.92K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HMSP
View details
OBAT
View details

About H.M. Sampoerna Tbk.

PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.

Read more on HMSP

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT